Plasma total cysteine as a risk factor for vascular disease: The European concerted action project

Circulation

Volumn 103, Issue 21, 2001, Pages 2544-2549

  El Khairy, Lina ^a   Ueland, Per M ^a   Refsum, Helga ^a   Graham, Ian M ^b   Vollset, Stein E ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Amino acids; Cardiovascular diseases; Risk factors

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035967497     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.21.2544     Document Type: Article

References (33)

1. Plasma homocysteine levels and mortality in patients with coronary artery disease
2. Plasma homocysteine as a risk factor for vascular disease: The European concerted action project
3. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
4. Total homocysteine and cardiovascular disease
5. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies
6. Hyperhomocysteinemia and thrombosis
7. Biological chemistry of thiols in the vasculature and in vascular-related disease
8. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells
9. The effect of cysteine on the auto-oxidation of homocysteine
10. Homocysteine, oxidative stress, and vascular disease
11. Endothelial cell injury due to copper-catalyzed endothelial cell injury from homocysteine
12. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
13. Cytotoxicity of cysteine in culture media
14. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor
15. Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy
16. Homocysteine species as components of plasma redox thiol status
17. Redox status and protein-binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration
18. 12, and folate
19. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects
20. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease
21. Blood glutathione and cysteine changes in cardiovascular disease
22. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: The hordaland homocysteine study
23. 6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
24. Fully automated fluorescence assay for determining total homocysteine in plasma
25. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
26. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency
27. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry
28. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteinehomocysteine mixed disulphide
29. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure
30. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
31. Serum glutathione in adolescent males predicts parental coronary heart disease
32. Glutathione: An overview of biosynthesis and modulation
33. Cysteine is a cardiovascular risk factor in hyperlipidemic patients